Key Takeaways
- • Vera Health raised a $28.5 million Series A led by Threshold Ventures, with participation from Mantis VC and SV Angel, bringing its total funding to $32 million.
- • Existing investors Y Combinator and Gradient tripled down in the round, per the company announcement.
- • Vera Health reports more than 800,000 clinicians across 190 countries use its clinical AI search engine, up from a few thousand a year earlier.
- • The company has reached this scale with a team of just 12 employees, largely through word of mouth.
- • Vera is free for licensed clinicians and trainees and states it is HIPAA and GDPR compliant and SOC 2 Type II certified.
Summary
Vera Health, a San Francisco-based clinical AI search company, announced a $28.5 million Series A financing led by Threshold Ventures, with participation from Mantis VC and SV Angel. Existing investors Y Combinator and Gradient also took part in the round, which brings the company's total funding to $32 million. The company said the capital will be used to accelerate its mission to close the gap between what medicine knows and what every patient receives.
According to the company, Vera has grown rapidly among clinicians. A year before the announcement, a few thousand clinicians used the platform; the company now reports more than 800,000, most of whom discovered it through a colleague. Vera states that it has been the most downloaded clinical app in the world across the App Store and Google Play every month since June. In September alone, the company says it was downloaded more times than OpenEvidence and Doximity combined, and monthly downloads had more than tripled since February. The company reports reaching clinicians in 190 countries, including approximately one in four physicians in Spain and Italy, with a team of only 12 employees.
Vera describes its product as a search engine that reasons like a clinician, finding and grading medical evidence and showing the source, strength and limits behind each answer. The platform is free for licensed clinicians and trainees, the company says it never trains on clinicians' questions, and it states that it is HIPAA and GDPR compliant and SOC 2 Type II certified. The figures on usage and download rankings are company-reported and were not independently verified in the announcement.
According to the company, Vera has grown rapidly among clinicians. A year before the announcement, a few thousand clinicians used the platform; the company now reports more than 800,000, most of whom discovered it through a colleague. Vera states that it has been the most downloaded clinical app in the world across the App Store and Google Play every month since June. In September alone, the company says it was downloaded more times than OpenEvidence and Doximity combined, and monthly downloads had more than tripled since February. The company reports reaching clinicians in 190 countries, including approximately one in four physicians in Spain and Italy, with a team of only 12 employees.
Vera describes its product as a search engine that reasons like a clinician, finding and grading medical evidence and showing the source, strength and limits behind each answer. The platform is free for licensed clinicians and trainees, the company says it never trains on clinicians' questions, and it states that it is HIPAA and GDPR compliant and SOC 2 Type II certified. The figures on usage and download rankings are company-reported and were not independently verified in the announcement.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.